DEM BioPharma Announces Poster Presentation Featuring DEM301 at the 2026 ASCO Gastrointestinal Cancers Symposium January 7, 2026
DEM BioPharma Establishes Leadership Team with Appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSO September 27, 2022
CHoMP: Westphal’s Dem Gobbles up $70M in Pfizer-backed Round to Fund Macrophage Cancer R&D June 27, 2022
